These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28533998)

  • 1. Ipilimumab as a Cause of Severe Pan-Colitis and Colonic Perforation.
    Shah R; Witt D; Asif T; Mir FF
    Cureus; 2017 Apr; 9(4):e1182. PubMed ID: 28533998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis.
    Yu C; Chopra IJ; Ha E
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():140092. PubMed ID: 25759760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-Onset Inflammatory Bowel Disease-Like Syndrome after Ipilimumab Therapy: A Case Report.
    Akel R; Anouti B; Tfayli A
    Case Rep Oncol; 2017; 10(2):456-461. PubMed ID: 28626406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab-Induced Enteritis without Colitis: A New Challenge.
    Messmer M; Upreti S; Tarabishy Y; Mazumder N; Chowdhury R; Yarchoan M; Holdhoff M
    Case Rep Oncol; 2016; 9(3):705-713. PubMed ID: 27920706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report.
    Nassri AB; Muenyi V; AlKhasawneh A; Ribeiro BS; Scolapio JS; Malespin M; de Melo SW
    World J Gastrointest Pharmacol Ther; 2019 Jan; 10(1):29-34. PubMed ID: 30697447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipilimumab and Nivolumab-Induced Colitis in a Patient With Recurrent Metastatic Melanoma.
    Moein HR; Rutledge B; Beydoun R; Ehrinpreis MN
    Cureus; 2021 Apr; 13(4):e14414. PubMed ID: 33987063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm.
    Klair JS; Girotra M; Hutchins LF; Caradine KD; Aduli F; Garcia-Saenz-de-Sicilia M
    Dig Dis Sci; 2016 Jul; 61(7):2132-9. PubMed ID: 26846115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early administration of infliximab for severe ipilimumab-related diarrhea in a critically ill patient.
    Merrill SP; Reynolds P; Kalra A; Biehl J; Vandivier RW; Mueller SW
    Ann Pharmacother; 2014 Jun; 48(6):806-10. PubMed ID: 24651165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study].
    Cuny P; Houot M; Ginisty S; Horowicz S; Plassart F; Mentec H; Eftekhari P
    Encephale; 2017 Feb; 43(1):81-84. PubMed ID: 27637870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fatal case of Immune thrombocytopenia secondary to the immune checkpoint inhibitor ipilimumab in a patient with BRAF wild type metastatic melanoma.
    Hadfield MJ; Mui G
    J Oncol Pharm Pract; 2020 Sep; 26(6):1530-1532. PubMed ID: 32063108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.
    Marthey L; Mateus C; Mussini C; Nachury M; Nancey S; Grange F; Zallot C; Peyrin-Biroulet L; Rahier JF; Bourdier de Beauregard M; Mortier L; Coutzac C; Soularue E; Lanoy E; Kapel N; Planchard D; Chaput N; Robert C; Carbonnel F
    J Crohns Colitis; 2016 Apr; 10(4):395-401. PubMed ID: 26783344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent perforation: an iatrogenic complication of colonoscopy.
    Jafri SM; Arora A
    Surg Laparosc Endosc Percutan Tech; 2007 Oct; 17(5):452-4. PubMed ID: 18049414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.
    Jain A; Lipson EJ; Sharfman WH; Brant SR; Lazarev MG
    World J Gastroenterol; 2017 Mar; 23(11):2023-2028. PubMed ID: 28373768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipilimumab-induced acute severe colitis treated by infliximab.
    Pagès C; Gornet JM; Monsel G; Allez M; Bertheau P; Bagot M; Lebbé C; Viguier M
    Melanoma Res; 2013 Jun; 23(3):227-30. PubMed ID: 23458760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple colon perforation as a fatal complication during treatment of metastatic melanoma with ipilimumab - case report.
    Dilling P; Walczak J; Pikiel P; Kruszewski WJ
    Pol Przegl Chir; 2014 Feb; 86(2):94-6. PubMed ID: 24670341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: colitis associated with anti-CTLA-4 therapy.
    Gupta A; De Felice KM; Loftus EV; Khanna S
    Aliment Pharmacol Ther; 2015 Aug; 42(4):406-17. PubMed ID: 26079306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Endoscopic, and Histologic Characteristics of Ipilimumab-Associated Colitis.
    Verschuren EC; van den Eertwegh AJ; Wonders J; Slangen RM; van Delft F; van Bodegraven A; Neefjes-Borst A; de Boer NK
    Clin Gastroenterol Hepatol; 2016 Jun; 14(6):836-842. PubMed ID: 26748223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious Colitis Associated With Ipilimumab Therapy.
    McCutcheon JL; McClain CM; Puzanov I; Smith TA
    Gastroenterology Res; 2014 Feb; 7(1):28-31. PubMed ID: 27785266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia Gravis Induced by Ipilimumab in a Patient With Metastatic Melanoma.
    Montes V; Sousa S; Pita F; Guerreiro R; Carmona C
    Front Neurol; 2018; 9():150. PubMed ID: 29666602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
    Shiuan E; Beckermann KE; Ozgun A; Kelly C; McKean M; McQuade J; Thompson MA; Puzanov I; Greer JP; Rapisuwon S; Postow M; Davies MA; Eroglu Z; Johnson D
    J Immunother Cancer; 2017; 5():8. PubMed ID: 28239462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.